Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk.
Pharmacogenetics and genomics 2010 May 20 (5): 315-26.
Northwood Emma L, Elliott Faye, Forman David, Barrett Jennifer H, Wilkie Murray J V, Carey Francis A, Steele Robert J C, Wolf Roland, Bishop Timothy, Smith Gilli
No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma.
Pharmacogenetics and genomics 2005 Oct 15 (10): 713-21.
McGreavey Louise E, Turner Faye, Smith Gillian, Boylan Katherine, Timothy Bishop D, Forman David, Roland Wolf C, Barrett Jennifer H,